Colchicine and HMG Co-A reductase inhibitors induced myopathy - A case report

被引：14
|
作者：
Torgovnick, Josh
Sethi, Nitin
Arsura, Edward
机构：
[1] St Vincents Hosp & Med Ctr, Dept Neurol, New York, NY 10011 USA
[2] Univ Virginia, Sch Med, Charlottesville, VA 22903 USA
来源：
NEUROTOXICOLOGY | 2006年 / 27卷 / 06期
关键词：
toxic myopathy; statin; colchicine;
D O I：
10.1016/j.neuro.2006.09.003
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：1126 / 1127
页数：2
相关论文
共 50 条
  • [21] Myopathy induced by HMG-CoA reductase inhibitors in rabbits: A pathological, electrophysiological, and biochemical study
    Nakahara, K
    Kuriyama, M
    Sonoda, Y
    Yoshidome, H
    Nakagawa, H
    Fujiyama, J
    Higuchi, I
    Osame, M
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 152 (01) : 99 - 106
  • [22] Lipid-lowering effect of HMG co-A reductase inhibitors compared with cholestyramines on vascular enclothelium in hypercholesterolemic and hypertensive patients
    Park, SJ
    Choi, DJ
    Hwang, JY
    [J]. CIRCULATION, 2004, 110 (17) : 119 - 119
  • [23] The efficacy of ezetimibe in renal transplant recipients intolerant to or not reaching cholesterol lower goals with HMG CO-A reductase inhibitors.
    Langone, AJ
    Chuange, P
    Schaefer, HM
    Kizilisik, T
    Shaffer, D
    Helderman, JH
    Nylander, W
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 469 - 469
  • [24] HMG-CoA reductase inhibitors - Myopathy in patients with genetic mutations (four case reports)
    不详
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2008, 12 (04) : 262 - 262
  • [25] Colchicine/simvastatinNecrotising myopathy: case report
    [J]. Reactions Weekly, 2022, 1922 (1) : 185 - 185
  • [26] Cerivastatin, a new synthetic HMG CO-A reductase inhibitor in the treatment of patients with primary hyperlipidaemia
    Kukharchuk, VV
    Solovieva, EY
    Rozhkova, TA
    Tvorogova, MG
    [J]. ATHEROSCLEROSIS, 1999, 144 : 196 - 197
  • [27] ZERO-CROSSING DERIVATIVE SPECTROPHOTOMETRY AND LIQUID CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE DETERMINATION OF CLOPIDOGREL IN PRESENCE OF HMG CO-A REDUCTASE INHIBITORS
    Sultana, Najma
    Arayne, Muhammad Saeed
    Nawaz, Muhammad
    Ali, Kiran Amir
    [J]. JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2013, 58 (01): : 1584 - 1589
  • [28] TRUNCATION OF THE 3' UNTRANSLATED REGION OF HMG CO-A REDUCTASE MESSENGER-RNA IN TESTIS
    MOSLEY, ST
    ROGERS, MR
    KALINOWSKI, SS
    CANTELLO, JL
    TANAKA, RD
    [J]. ARTERIOSCLEROSIS, 1990, 10 (05): : A824 - A824
  • [29] Antiplatelets/HMG-CoA-reductase-inhibitors/MannitolLack of efficacy: case report
    [J]. Reactions Weekly, 2022, 1937 (1) : 80 - 80
  • [30] Do hyperlipidemic patients with elevated baseline liver enzymes have a higher risk of hepatotoxicity from HMG Co-A reductase inhibitors (statins)?
    Chalasani, N
    Liangpunsakul, S
    Murray, M
    Kesterson, J
    Hall, SD
    [J]. HEPATOLOGY, 2003, 38 (04) : 697A - 697A
12345